Seattle's Parse Biosciences lands another legal victory in patent dispute
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Financial Post10d
Parse Biosciences Invalidates All 10x Genomics' Patent Claims Asserted Against Its Products
SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent ...
AFP1mon
Parse Biosciences Quadruples Sample Multiplexing Abilities for Evercode WT Mega Kits
Parse Biosciences, a leader in accessible and scalable single cell sequencing solutions, today announced a significant expansion of its Evercode™ WT Mega Kit functionality. Researchers can now ...
Business Wire1mon
Parse Biosciences Welcomes Admera Health as Newest Member of Certified Service Provider Network
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that Admera Health, a premier provider of Next ...
Yahoo Finance10d
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
SEATTLE, February 04, 2025--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal ...
Yahoo Finance1mon
Parse Biosciences Quadruples Sample Multiplexing Abilities for Evercode WT Mega Kits
SEATTLE, January 07, 2025--(BUSINESS WIRE)--Parse Biosciences, a leader in accessible and scalable single cell sequencing solutions, today announced a significant expansion of its Evercode™ WT ...
Business Wire9d
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent and ...
Yahoo Finance10d
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
SEATTLE, February 04, 2025--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board ...